Anti-ZFYVE27 monoclonal antibody

Pre-made anti-ZFYVE27 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZFYVE27/ZFYVE27 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2315-Ab-1/ GM-Tg-hg-IP2315-Ab-2Anti-Human ZFYVE27 monoclonal antibodyHuman
GM-Tg-rg-IP2315-Ab-1/ GM-Tg-rg-IP2315-Ab-2Anti-Rat ZFYVE27 monoclonal antibodyRat
GM-Tg-mg-IP2315-Ab-1/ GM-Tg-mg-IP2315-Ab-2Anti-Mouse ZFYVE27 monoclonal antibodyMouse
GM-Tg-cynog-IP2315-Ab-1/ GM-Tg-cynog-IP2315-Ab-2Anti-Cynomolgus/ Rhesus macaque ZFYVE27 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2315-Ab-1/ GM-Tg-felg-IP2315-Ab-2Anti-Feline ZFYVE27 monoclonal antibodyFeline
GM-Tg-cang-IP2315-Ab-1/ GM-Tg-cang-IP2315-Ab-2Anti-Canine ZFYVE27 monoclonal antibodyCanine
GM-Tg-bovg-IP2315-Ab-1/ GM-Tg-bovg-IP2315-Ab-2Anti-Bovine ZFYVE27 monoclonal antibodyBovine
GM-Tg-equg-IP2315-Ab-1/ GM-Tg-equg-IP2315-Ab-2Anti-Equine ZFYVE27 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2315-Ab-1/ GM-Tg-hg-IP2315-Ab-2; GM-Tg-rg-IP2315-Ab-1/ GM-Tg-rg-IP2315-Ab-2;
GM-Tg-mg-IP2315-Ab-1/ GM-Tg-mg-IP2315-Ab-2; GM-Tg-cynog-IP2315-Ab-1/ GM-Tg-cynog-IP2315-Ab-2;
GM-Tg-felg-IP2315-Ab-1/ GM-Tg-felg-IP2315-Ab-2; GM-Tg-cang-IP2315-Ab-1/ GM-Tg-cang-IP2315-Ab-2;
GM-Tg-bovg-IP2315-Ab-1/ GM-Tg-bovg-IP2315-Ab-2; GM-Tg-equg-IP2315-Ab-1/ GM-Tg-equg-IP2315-Ab-2
Products NameAnti-ZFYVE27 monoclonal antibody
Formatmab
Target NameZFYVE27
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZFYVE27 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2315-Ag-1Recombinant multi-species ZFY27/ ZFYVE27/ PROTRUDIN protein
    ORF Viral VectorpGMLV000013mouse Zfyve27 Lentivirus plasmid
    ORF Viral VectorvGMLV000013mouse Zfyve27 Lentivirus particle


    Target information

    Target IDGM-IP2315
    Target NameZFYVE27
    Gene ID118813,319740,309376,707273,486825,101081083,514383,100060913
    Gene Symbol and Synonyms2210011N02Rik,9530077C24Rik,PROTRUDIN,SPG33,ZFYVE27
    Uniprot AccessionQ5T4F4,Q6P7B7,Q5BIM5
    Uniprot Entry NameZFY27_HUMAN,ZFY27_RAT,ZFY27_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000155256
    Target ClassificationN/A

    The target: ZFYVE27, gene name: ZFYVE27, also named as PROTRUDIN, SPG33. This gene encodes a protein with several transmembrane domains, a Rab11-binding domain and a lipid-binding FYVE finger domain. The encoded protein appears to promote neurite formation. A mutation in this gene has been reported to be associated with hereditary spastic paraplegia, however the pathogenicity of the mutation, which may simply represent a polymorphism, is unclear. [provided by RefSeq, Mar 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.